XML 88 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Geneos Therapeutics, Inc. - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jun. 01, 2020
Mar. 31, 2022
Nov. 30, 2020
Feb. 28, 2019
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Feb. 28, 2021
Jun. 30, 2020
Jan. 31, 2020
Noncontrolling Interest [Line Items]                      
Payments to acquire additional interest in subsidiaries           $ 1,999,998 $ 0 $ 1,399,999      
Gain on deconsolidation of Geneos           0 0 4,121,075      
Share in net loss of Geneos           2,165,213 434,387 $ 4,584,610      
Geneos Therapeutics, Inc.                      
Noncontrolling Interest [Line Items]                      
Percentage of ownership                   47.00%  
Series A-2 One Preferred Stock                      
Noncontrolling Interest [Line Items]                      
Remeasurement of Geneos Series A-1 preferred stock   $ 165,000       165,215          
Share in net loss of Geneos   2,200,000       2,165,213          
Investment in Geneos   $ 0       $ 0 $ 1,999,998        
Geneos Therapeutics, Inc.                      
Noncontrolling Interest [Line Items]                      
Noncontrolling interest, ownership percentage by parent   28.00% 36.00% 61.00%         35.00%   52.00%
Geneos Therapeutics, Inc.                      
Noncontrolling Interest [Line Items]                      
Payments to acquire additional interest in subsidiaries     $ 1,400,000 $ 1,200,000              
Stock purchase agreement, commitment of additional investment                   $ 800,000 $ 800,000
Gain on deconsolidation of Geneos $ 4,100,000                    
Remeasurement of Geneos Series A-1 preferred stock $ 2,400,000                    
Loss from equity method investment, recorded and allocated to investment         $ 1,500,000            
Share in net loss of Geneos         434,000            
Investment in Geneos         0            
Geneos Therapeutics, Inc. | Common stock                      
Noncontrolling Interest [Line Items]                      
Share in net loss of Geneos         819,000            
Investment in Geneos         0            
Geneos Therapeutics, Inc. | Series A-1 Preferred Stock                      
Noncontrolling Interest [Line Items]                      
Share in net loss of Geneos         4,200,000            
Investment in Geneos         $ 0            
Geneos Therapeutics, Inc. | Preferred stock                      
Noncontrolling Interest [Line Items]                      
Payments to acquire additional interest in subsidiaries   $ 2,000,000